Company intelligence / Profile preview

Benela

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Benela is a health technology company focused on longevity and personalized wellness through data-driven insights. The company provides a platform that integrates biological testing, such as blood biomarkers and genetic analysis, with personalized supplement regimens and lifestyle recommendations. By leveraging AI and clinical research, Benela aims to optimize metabolic health and slow the biological aging process for its users. Their services are primarily delivered through a direct-to-consumer model, offering subscription-based health monitoring and tailored nutritional interventions.

Therapeutic areas: Metabolic DisordersOther
Industry: Food & Nutrition

Beyond the preview

Go deeper on Benela.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benela.

Explore the full profile